Skip to content

Latest News

Aurobindo Pharma jumps 5% after subsidiary gets USFDA nod for osteoarthritis pain relief drug

Aurobindo Pharma jumps 5% after subsidiary gets USFDA nod for osteoarthritis pain relief drug

The drugmaker said that its step-down subsidiary company Aurolife Pharma has received USFDA#39;s approval to manufacture and market Diclofenac Sodium Topical Solution USP. Read More ​ The drugmaker said that its step-down subsidiary company Aurolife Pharma has received USFDA#39;s approval to… Read More »Aurobindo Pharma jumps 5% after subsidiary gets USFDA nod for osteoarthritis pain relief drug

en_USEnglish